These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15844701)

  • 1. Inflammation-related erythrocyte aggregation in patients with inflammatory bowel disease.
    Zilberman L; Rogowski O; Rozenblat M; Shapira I; Serov J; Halpern P; Dotan I; Arber N; Berliner S
    Dig Dis Sci; 2005 Apr; 50(4):677-83. PubMed ID: 15844701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.
    Gasparetto M; Guariso G; Pozza LV; Ross A; Heuschkel R; Zilbauer M
    BMC Gastroenterol; 2016 Mar; 16():35. PubMed ID: 26976427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of elafin in peripheral blood in inflammatory bowel disease patients and its clinical significance].
    Zhang W; Teng GG; Tian Y; Wang HH
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1120-3. PubMed ID: 27095781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Koutroumpakis E; Ramos-Rivers C; Regueiro M; Hashash JG; Barrie A; Swoger J; Baidoo L; Schwartz M; Dunn MA; Koutroubakis IE; Binion DG
    Dig Dis Sci; 2016 Mar; 61(3):865-71. PubMed ID: 26514677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis.
    Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW
    Haemostasis; 1999; 29(6):326-35. PubMed ID: 10844406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
    Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
    J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinical and endoscopic indices in IBD patients in University Clinical Hospital Mostar.
    Babić E; Bevanda M; Karin M; Volarić M; Bevanda D; Glibo DB; Bogut A
    Psychiatr Danub; 2016 Dec; 28 Suppl 2():242-246. PubMed ID: 28035129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased leukocyte adhesiveness/aggregation is the single best biochemical indicator of disease activity in adolescent patients with inflammatory bowel disease.
    Arber N; Berliner S; Reif S; Dotan I; Liberman E; Aschkenasy M; Vila Y; Gilat T; Bujanover Y
    J Med; 1996; 27(5-6):319-31. PubMed ID: 9151200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease.
    Van Bodegraven AA; Tuynman HA; Schoorl M; Kruishoop AM; Bartels PC
    Scand J Gastroenterol; 1995 Jun; 30(6):580-5. PubMed ID: 7569767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
    Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
    J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Zhang W; Teng G; Wu T; Tian Y; Wang H
    Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.